HomeSpeakersAgendaContact

ProductUpdated on 9 February 2025

sustainable & standardized human biomaterials

Johannes Hackethal

CEO, founder at THT Biomaterials GmbH

Vienna, Austria

About

THT Biomaterials GmbH was founded in 2020, to isolate multiple sustainable and standardized human biomaterials from placenta batches, to replace animal-derived biomaterials in a broad spectrum of applications, to speed up and de-risk many medical translation processes.

Human placenta is collected after informed consent and serological testings.

Our first products are:
Collagen type-I
Collagen type-IV
Laminin type-111
HUMAN PLACENTA Substrate
HUMAN PLACENTA ECM
(more products pending)

Our first applications are:
defined 2D coatings
3D gels/tissue ink
organoids
Lab-on-chips

barrier models
membranes
filler
(more applications pending)

Contact us

Applies to

  • Life Science, Healthcare & Cosmetics

Organisation

THT Biomaterials GmbH

Company (SME)

Vienna, Austria

Similar opportunities